Biodesix Other Share Holders Equity 2020-2024 | BDSX
Biodesix other share holders equity from 2020 to 2024. Other share holders equity can be defined as field containing the sum of all current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
| Biodesix Annual Other Share Holders Equity (Millions of US $) |
|
|---|---|
| 2023 | $ |
| 2022 | $ |
| 2021 | $ |
| 2020 | $ |
| 2019 | $ |
| Biodesix Quarterly Other Share Holders Equity (Millions of US $) |
|
|---|---|
| 2024-09-30 | |
| 2024-06-30 | |
| 2024-03-31 | |
| 2023-12-31 | |
| 2023-09-30 | |
| 2023-06-30 | |
| 2023-03-31 | |
| 2022-12-31 | |
| 2022-09-30 | |
| 2022-06-30 | |
| 2022-03-31 | |
| 2021-12-31 | |
| 2021-09-30 | |
| 2021-06-30 | |
| 2021-03-31 | |
| 2020-12-31 | |
| 2020-09-30 | |
| 2020-06-30 | $0 |
| 2020-03-31 | $0 |
| 2019-12-31 | |
| 2019-09-30 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.175B | $0.049B |
| Biodesix Inc. is a data-driven diagnostic solutions company. It offers blood-based tests across the lung cancer continuum of care. The company also offers include diagnostic research, clinical research, development, and testing services to biopharmaceutical companies, as well as develops and commercializes companion diagnostics. Biodesix Inc. is based in Boulder, Colorado. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $93.604B | 11.61 |
| Cencora (COR) | United States | $48.412B | 17.85 |
| DiDi Global (DIDIY) | China | $22.941B | 0.00 |
| Natera (NTRA) | United States | $22.359B | 0.00 |
| ICON (ICLR) | Ireland | $17.552B | 15.63 |
| Viatris (VTRS) | United States | $15.815B | 4.87 |
| Avantor (AVTR) | United States | $13.857B | 20.78 |
| Revvity (RVTY) | United States | $13.522B | 23.49 |
| CochLear (CHEOY) | Australia | $12.586B | 0.00 |
| BioMerieux (BMXMF) | France | $12.119B | 0.00 |
| Solventum (SOLV) | United States | $12.029B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.624B | 29.93 |
| Charles River Laboratories (CRL) | United States | $9.930B | 19.19 |
| HealthEquity (HQY) | United States | $9.139B | 49.60 |
| Doximity (DOCS) | United States | $8.961B | 52.75 |
| Sonic Healthcare (SKHHY) | Australia | $8.813B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.977B | 32.47 |
| Life Times (LTH) | United States | $5.046B | 33.40 |
| Organon (OGN) | United States | $3.835B | 3.87 |
| Sotera Health (SHC) | United States | $3.515B | 18.80 |
| BrightSpring Health Services (BTSG) | United States | $3.265B | 69.44 |
| Surgery Partners (SGRY) | United States | $2.968B | 33.84 |
| Concentras Parent (CON) | United States | $2.735B | 0.00 |
| PACS (PACS) | United States | $2.522B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.320B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.255B | 0.00 |
| Premier (PINC) | United States | $2.155B | 11.21 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.995B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.980B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.791B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.635B | 42.90 |
| Progyny (PGNY) | United States | $1.275B | 25.81 |
| Pediatrix Medical (MD) | United States | $1.267B | 12.40 |
| CareDx (CDNA) | United States | $1.211B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.193B | 0.00 | |
| AMN Healthcare Services Inc (AMN) | United States | $0.978B | 6.62 |
| Embecta (EMBC) | United States | $0.808B | 5.38 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
| Agilon Health (AGL) | United States | $0.733B | 0.00 |
| SBC Medicals (SBC) | United States | $0.670B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.627B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.526B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.467B | 0.00 |
| DocGo (DCGO) | United States | $0.420B | 15.85 |
| Enhabit (EHAB) | United States | $0.376B | 32.48 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.304B | 0.00 |
| ModivCare (MODV) | United States | $0.250B | 13.54 |
| LifeMD (LFMD) | United States | $0.246B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.206B | 0.00 |
| Nutex Health (NUTX) | United States | $0.173B | 0.00 |
| Beauty Health (SKIN) | United States | $0.173B | 0.00 |
| MultiPlan (MPLN) | United States | $0.114B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.094B | 0.00 |
| So-Young (SY) | China | $0.093B | 17.98 |
| Singular Genomics Systems (OMIC) | United States | $0.055B | 0.00 |
| OncoCyte (OCX) | United States | $0.045B | 0.00 |
| NeueHealth (NEUE) | United States | $0.042B | 1.11 |
| Co-Diagnostics (CODX) | United States | $0.034B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.031B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.027B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.022B | 0.00 |
| Oncology Institute (TOI) | United States | $0.012B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.010B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| KindlyMD (KDLY) | United States | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |